Some people may face intense, if transient, side effects, called reactogenicity, from Moderna’s COVID-19 vaccine.
Reinfections hint that immunity against COVID-19 may be fragile and wane relatively quickly, with implications not just for the risks facing recovered patients, but also for how long future vaccines might protect people.
Eight of a dozen Mississippi juveniles convicted of capital murder since 2012 have received life-without-parole sentences. All but one are Black.
The Pentagon staged its first “Zoom Court” linking the courtroom at Guantánamo Bay to a secret location in the United States for a classified hearing in a military commissions case.
Scrutiny of school openings in countries where the virus is resurgent paints a more complex picture of the risks and how they might be managed.
Nita Patel, a senior director in the vaccine development department at Novavax, often works 18-hour days in the lab.
Pfizer and BioNTech now report 95% efficacy for their vaccine candidate. “This is a remarkable and very reassuring situation that we find ourselves in,” says Trudie Lang of the Global Health Network at Oxford University.
After sitting in three planes and walking through four airports, Neyla couldn’t put her mother, who had stage 4 cancer, at risk of contracting COVID-19.
Relying on an ultracold supply chain for vaccines is expensive, and in some places it may make more sense to distribute a vaccine that can tolerate warmer temperatures even if it’s less effective.
Human rights groups have criticized the shutdown for hampering access to information about COVID-19, as well as making it harder to distribute food and medical aid to civilians displaced by conflict.
Although the clinical trial results may not guarantee an equally high level of real-world protection, the success indicates the vaccine could be effective enough to stop the pandemic if widely distributed.
ScienceInsider interviews New York University epidemiologist and infectious disease expert Céline Gounder, one of 13 people President-elect Joe Biden has named to a coronavirus task force.